PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.560.02 (-0.36%)
5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.46%
Revenue growth similar to METSB.HE's 14.46%. Walter Schloss would see if both companies share industry tailwinds.
-41.81%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
14800.00%
EBIT growth similar to METSB.HE's 14800.00%. Walter Schloss might infer both firms share similar operational efficiencies.
14800.00%
Operating income growth similar to METSB.HE's 14800.00%. Walter Schloss would assume both share comparable operational structures.
445.83%
Net income growth comparable to METSB.HE's 445.83%. Walter Schloss might see both following similar market or cost trajectories.
444.12%
EPS growth similar to METSB.HE's 444.12%. Walter Schloss would assume both have parallel share structures and profit trends.
444.12%
Similar diluted EPS growth to METSB.HE's 444.12%. Walter Schloss might see standard sector or cyclical influences on both firms.
-0.13%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.13%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-106.36%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-150.08%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-0.63%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-1.75%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-1.70%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
57.19%
10Y OCF/share CAGR in line with METSB.HE's 57.19%. Walter Schloss would see both as similarly efficient over the decade.
-121.47%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-147.18%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-45.61%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-78.25%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-79.10%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
109.02%
10Y equity/share CAGR in line with METSB.HE's 109.02%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
36.19%
5Y equity/share CAGR is in line with METSB.HE's 36.19%. Walter Schloss would see parallel mid-term profitability and retention policies.
20.75%
3Y equity/share CAGR similar to METSB.HE's 20.75%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.70%
AR growth well above METSB.HE's 17.70%. Michael Burry fears inflated revenue or higher default risk in the near future.
11.16%
Inventory growth well above METSB.HE's 11.16%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.21%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-7.35%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.78%
Debt growth far above METSB.HE's 0.78%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.04%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.